 |
| October
29, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Dr. Yuichi Iwaki, Founder, President,
& CEO, MediciNova |
| In
this Q&A, Iwaki discusses what led him
to found the company, how its lean
operating model and non-dilutive
partnerships help advance a late-stage
pipeline, the milestones ahead as MN-166
approaches discussions with FDA, and what
he'd change about drug development
timelines industry-wide. More |
|
|
- 60 Degrees Pharmaceuticals: Partnership With
The University of Southern Mississippi to
Evaluate Castanospermine in Nonclinical Models
of Alpha-Gal Syndrome More
- Supernus: Chloe Kim Is Changing the
Conversation Around ADHD in Women With Qelbree
for ‘Ms. Represented’ Campaign More
|
|
|
|
- Indivior: Third Quarter 2026 Financial
Results
More
- More on Rockville’s Kaigene Signing
Celltrion Deal for Autoimmune Drug Candidate More
- October 30, 2026: BioPharmCatalyst Weekly
Watchlist: Key Catalysts Due Within the Next 6
Months More
- Vanda Pharmaceuticals: Third Quarter 2026
Financial Results More
|
|
 |
| Turn
unstructured bladder cancer data
into actionable real-world
insights. |
| Download
the case study to learn how. |
|
|
- Big4Bio CEO Weekly Q&A: Dr.
Yuichi Iwaki, Founder, President, & CEO,
MediciNova
More
- Biotech & Pharma Updates | October 28,
2026 More
- FDA Charts Path for Approval of
Individualized Gene Editing Therapies More*
More
- FDA’s Rare Disease Framework Aims to ‘Stand
the Test of Time’ More
- More on Maryland’s Senseonics Beginning
First Human Study of Transmitter-Free Glucose
Monitor More
- More on RIVANNA Securing FDA Clearance for
AI-Powered Bone Visualization Software More
- More on Rockville’s MacroGenics Reporting
Encouraging Phase 2 Cancer Results as LINNET
Trial Advances After Safety Hold More
- More on Vanda Pharmaceuticals
Targeting Major GLP-1 Market Challenge With
Positive Trial Outcomes More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
 |
| Slone
Partners Places Farhad Ghavami as
Chief Executive Officer at
SeqCenter |
|
Learn More
→ |
|
|
- Biopharma Cuts at Manufacturing
Plants Expected to Affect 4,000+ More
- OPPORTUNITY: Chief Growth Officer, Remote More
- OPPORTUNITY: Executive Director,
Remote More
- OPPORTUNITY: Head of Global Research &
Development, Columbia, MD More
- People on the Move: Katrina Downie Joins
Thermo Fisher Scientific as Vice President of
Commercial BioProduction for North America More
- Senate President Bill Ferguson Names Sen.
Brian Feldman Maryland’s Senate Economic
Development Chief at TEDCO Entrepreneur Expo More
- Slone Partners: How Investors Are Impacting
Talent Strategies in Life Sciences and
Healthcare More
- Slone Partners: Leading Through AI -
The New Playbook for Healthtech Executives
More
|
|
 |
Events
|
Note:
Events may be in any Big4Bio region or
virtual |
|
- PODD: Partnership Opportunities in
Drug Delivery Oct
29-30
- Aggression in Mice: Bridging
Evidence, Best Practices, and Scientific
Rigor
Nov 4
- Scaling Academic Research Programs
Through Strategic Colony Management
Partnerships Nov
11
- 23rd Annual Pantheon Awards
Nov 12
- 2026 LSPA Patient Summit Nov
12
- Patient Pathways (Use code 26B4B10
for 10% off) Nov
17-20
- Pricing & Contracting WEST (Use
code 26B4B10 for 10% off) Dec
7-8
- Trade
and Channel Strategies (Use code 26B4B10
for 10% off) Dec
8-10
- Advancing
Drug Development Forum Dec
10
|
SEE FULL
EVENT SCHEDULE AT THE BIOCALENDAR
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
